Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.395
-0.005 (-0.21%)
At close: Dec 5, 2025
-7.88%
Market Cap 1.61B
Revenue (ttm) 648.96M
Net Income (ttm) 56.90M
Shares Out 671.34M
EPS (ttm) 0.08
PE Ratio 28.26
Forward PE n/a
Dividend 0.02 (0.86%)
Ex-Dividend Date Sep 25, 2025
Volume 168,005
Average Volume 166,751
Open 2.400
Previous Close 2.400
Day's Range 2.360 - 2.400
52-Week Range 1.750 - 2.750
Beta 0.23
RSI 40.17
Earnings Date Nov 20, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,357
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.

Financial Statements

News

There is no news available yet.